Asa Karlsdottir

Summary

Affiliation: Haukeland University Hospital
Country: Norway

Publications

  1. ncbi Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer
    Asa Karlsdottir
    Centre for Clinical Research, Haukeland University Hospital, N 5021, Bergen, Norway
    Acta Oncol 45:454-62. 2006
  2. ncbi Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity
    Asa Karlsdottir
    Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway
    Int J Radiat Oncol Biol Phys 70:1478-86. 2008
  3. ncbi Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy
    Asa Karlsdottir
    Section of Oncology, Institute of Medicine, Medical Faculty, University of Bergen, Bergen, Norway
    Acta Oncol 48:874-81. 2009
  4. ncbi Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum
    Ludvig Paul Muren
    Section of Oncology, Medical Faculty, University of Bergen, Norway
    Radiother Oncol 75:293-302. 2005
  5. ncbi On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning
    Ludvig Paul Muren
    Department of Oncology and Medical Physics, Haukeland University Hospital, N-5021 Bergen, Norway
    Radiother Oncol 70:11-9. 2004
  6. ncbi Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate
    Nils Hovdenak
    Division of Gastroenterology, Institute of Medicine, Haukeland University Hospital, University of Bergen, Norway
    Acta Oncol 42:741-8. 2003
  7. ncbi Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences
    Ludvig Paul Muren
    Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway
    Int J Radiat Oncol Biol Phys 71:1034-41. 2008

Collaborators

Detail Information

Publications7

  1. ncbi Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer
    Asa Karlsdottir
    Centre for Clinical Research, Haukeland University Hospital, N 5021, Bergen, Norway
    Acta Oncol 45:454-62. 2006
    ..07) for CSS. A dose of 70 Gy combined with hormonal treatment improves PSA failure free survival and survival in localised prostate cancer compared with doses of 64-66 Gy...
  2. ncbi Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity
    Asa Karlsdottir
    Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway
    Int J Radiat Oncol Biol Phys 70:1478-86. 2008
    ..To investigate the incidence, time course, and relation to irradiated volumes of late morbidity after three-dimensional conformal radiation therapy (RT) for prostate cancer...
  3. ncbi Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy
    Asa Karlsdottir
    Section of Oncology, Institute of Medicine, Medical Faculty, University of Bergen, Bergen, Norway
    Acta Oncol 48:874-81. 2009
    ..To analyse the impact of radiation dose escalation and hormone treatment in prostate cancer patients according to risk groups...
  4. ncbi Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum
    Ludvig Paul Muren
    Section of Oncology, Medical Faculty, University of Bergen, Norway
    Radiother Oncol 75:293-302. 2005
    ..To study the impact of the new ICRU 62 'Planning organ at Risk Volume' (PRV) concept on the relationship between rectum dose-volume histogram (DVH) data and toxicity...
  5. ncbi On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning
    Ludvig Paul Muren
    Department of Oncology and Medical Physics, Haukeland University Hospital, N-5021 Bergen, Norway
    Radiother Oncol 70:11-9. 2004
    ..Use of anterior margins only caused large shifts in the DVHs in the clinically significant dose range, while only minor shifts were seen when using both anterior and posterior margins...
  6. ncbi Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate
    Nils Hovdenak
    Division of Gastroenterology, Institute of Medicine, Haukeland University Hospital, University of Bergen, Norway
    Acta Oncol 42:741-8. 2003
    ..The development and timing of symptoms may give clues to pathogenesis, treatment, and prophylaxis...
  7. ncbi Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences
    Ludvig Paul Muren
    Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway
    Int J Radiat Oncol Biol Phys 71:1034-41. 2008
    ..We present planning and early clinical outcomes of a study of intensity-modulated radiotherapy (IMRT) for locally advanced prostate cancer...